ICU MEDICAL INC
ICUINASDAQ🏆 #1474 by market capEarnings Nov 4US Equity
$163.44▼ $0.59 (−0.36%)
🌙 After hours$163.44▲ 0.00%Regular close · extended-hours price shownTrack ICUI
Get earnings, price moves & breaking news on Telegram
24h▼ 0.4%
7d▲ 1.5%
14d▲ 4.9%
30d▼ 7.0%
ytd▲ 14.7%
1y▲ 39.9%
🏦Market Cap
$4.08B
Small Cap
📈Revenue Growth (YoY)
-6.4%
Declining
📊Gross Margin
37.6%
Healthy
💵FCF Margin
7.1%
Moderate
⚖️P/S Ratio
1.9x
Cheap
Otter Score
60
Fair
ICU MEDICAL INC
ICUIAnalyst Ratings
Price
$163.44
Total
12
Raised
2
Lowered
1
Avg PT
$186.40
H / L
$200 / $163
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Piper Sandler | Reiterated | Overweight | 2026-08-07 | $163.00 | −0.30% |
BTIG | Reiterated | Buy | 2026-08-07 | $200.00 | +22.40% |
Needham | Reiterated | Buy | 2026-08-07 | $187.00 | +14.40% |
Keybanc | Reiterated | Overweight | 2026-07-21 | $182.00 | +11.40% |
Raymond James | Reiterated | Strong Buy | 2025-08-08 | $200.00 | +22.40% |
Jefferies | Upgraded | Hold → Buy | 2024-12-11 | $183.00 | +12.00% |
KeyBanc | Reiterated | Overweight | 2021-01-08 | $182.00 | +11.40% |
Gabelli & Co. | Reiterated | Buy | 2016-03-11 | — | — |
PiperJaffray | Reiterated | Overweight | 2015-08-11 | — | — |
Roth Capital | Reiterated | Buy | 2015-08-11 | — | — |
CJS Securities | Upgraded | Market Perform → Market Outperform | 2014-09-23 | — | — |
Benchmark | Downgraded | Buy → Hold | 2013-05-09 | — | — |
Institution
Piper Sandler
Reiterated · Overweight · 2026-08-07
$163.00
−0.30%
BTIG
Reiterated · Buy · 2026-08-07
$200.00
+22.40%
Needham
Reiterated · Buy · 2026-08-07
$187.00
+14.40%
Keybanc
Reiterated · Overweight · 2026-07-21
$182.00
+11.40%
Raymond James
Reiterated · Strong Buy · 2025-08-08
$200.00
+22.40%
Jefferies
Upgraded · Hold → Buy · 2024-12-11
$183.00
+12.00%
KeyBanc
Reiterated · Overweight · 2021-01-08
$182.00
+11.40%
Gabelli & Co.
Reiterated · Buy · 2016-03-11
—
—
PiperJaffray
Reiterated · Overweight · 2015-08-11
—
—
Roth Capital
Reiterated · Buy · 2015-08-11
—
—
CJS Securities
Upgraded · Market Perform → Market Outperform · 2014-09-23
—
—
Benchmark
Downgraded · Buy → Hold · 2013-05-09
—
—
One row per institution · price target from the firm's latest published target